EQS-Adhoc: SYNLAB AG: Proceedings of the Portuguese Competition Authority against entities of SYNLAB
|
EQS-Ad-hoc: SYNLAB AG / Key word(s): Legal Matter
SYNLAB AG: Proceedings of the Portuguese Competition Authority against entities of SYNLAB
04-Jan-2023 / 18:58 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
SYNLAB AG announces that the Portuguese Competition Authority (Autoridade da Concorrência) has initiated proceedings against, inter alia, two Portuguese entities of SYNLAB Group (“SYNLAB”) and has associated SYNLAB AG with the proceedings regarding potential violations of competition law in Portugal. The Portuguese Competition Authority has formally notified the respective objections.
The objections concern the operations in the Portuguese market for laboratory diagnostics between 2016 and March 2022. SYNLAB will review the objections carefully and decide upon next steps afterwards. The estimated outcome of the proceedings, including the risk of a potential penalty being imposed on SYNLAB, cannot be determined before the completion of this review and progress in the proceedings.
04-Jan-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
SYNLAB AG |
|
Moosacher Straße 88 |
|
80809 Munich |
|
Germany |
| Phone: |
+49 1701183753 |
| E-mail: |
[email protected] |
| Internet: |
www.synlab.com/ |
| ISIN: |
DE000A2TSL71 |
| WKN: |
A2TSL7 |
| Indices: |
SDAX |
| Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: |
1527673 |
| |
| End of Announcement |
EQS News Service |
1527673 04-Jan-2023 CET/CEST
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Umsatzerlöse1 |
0,00 |
1.807,90 |
1.906,10 |
2.621,20 |
3.764,92 |
3.250,52 |
2.635,16 |
| EBITDA1,2 |
0,00 |
382,90 |
397,40 |
679,20 |
1.179,89 |
532,98 |
353,28 |
| EBITDA-Marge3 |
0,00 |
21,18 |
20,85 |
25,91 |
31,34 |
16,40 |
|
| EBIT1,4 |
0,00 |
138,80 |
71,90 |
315,50 |
914,53 |
231,68 |
59,16 |
| EBIT-Marge5 |
0,00 |
7,68 |
3,77 |
12,04 |
24,29 |
7,13 |
2,25 |
| Jahresüberschuss1 |
0,00 |
-42,10 |
-108,00 |
259,10 |
627,54 |
152,52 |
92,96 |
| Netto-Marge6 |
0,00 |
-2,33 |
-5,67 |
9,88 |
16,67 |
4,69 |
3,53 |
| Cashflow1,7 |
0,00 |
120,30 |
238,60 |
904,70 |
1.011,70 |
629,63 |
363,13 |
| Ergebnis je Aktie8 |
0,00 |
-0,19 |
-0,49 |
1,16 |
2,82 |
0,68 |
0,42 |
| Dividende8 |
0,00 |
0,00 |
0,00 |
0,00 |
0,33 |
0,33 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: Deloitte
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| Synlab |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| A2TSL7 |
11,460 |
|
2.546,67 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 17,63 |
21,74 |
0,81 |
16,95 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 1,09 |
7,01 |
0,97 |
9,20 |
| Dividende '22 in € |
Dividende '23 in € |
Div.-Rendite '23
in % |
Hauptversammlung |
| 0,33 |
0,00 |
0,00 |
17.05.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
| 08.05.2024 |
08.08.2024 |
07.11.2024 |
25.03.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| 3,17% |
4,04% |
0,70% |
6,31% |
|
|
SYNLAB AG DE000A2TSL71